FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2026499711> ?p ?o ?g. }

• W2026499711 endingPage "7464" @default.
• W2026499711 startingPage "7460" @default.
• W2026499711 abstract "Intestinal epithelia are in intimate contact with subepithelial and intraepithelial lymphocytes. When stimulated, mucosal lymphocytes generate cytokines that act locally and influence functional aspects of many cell types. We have previously defined functional epithelial receptors for interferon-γ, interleukin (IL)-4, and a recently described IL-4-like cytokine IL-13. In this study, we examine the ion transport properties of T84 cells, a crypt-like epithelial cell line, following exposure to IL-4 and IL-13. Basolateral exposure of epithelial monolayers to both IL-4 and IL-13 attenuated epithelial barrier function and increased paracellular flux of a dextran marker by greater than 65% in a dose- and time-dependent fashion. Stimulated Cl- secretion, as measured by epithelial short circuit current, however, was diminished only by IL-4 and not IL-13, demonstrating cytokine specificity in this epithelial function. Decreased Cl- secretion following IL-4 exposure was associated with diminished Cl- channel activity and IL-4 pretreatment of epithelia decreased expression of the cystic fibrosis transmembrane regulator. Finally, stimulated fluid transport across cultured epithelia was diminished following exposure to IL-4, but not IL-13. These results indicate that while post-receptor signaling events induced by IL-13 and IL-4 may be similar, end point function is cytokine-specific. Intestinal epithelia are in intimate contact with subepithelial and intraepithelial lymphocytes. When stimulated, mucosal lymphocytes generate cytokines that act locally and influence functional aspects of many cell types. We have previously defined functional epithelial receptors for interferon-γ, interleukin (IL)-4, and a recently described IL-4-like cytokine IL-13. In this study, we examine the ion transport properties of T84 cells, a crypt-like epithelial cell line, following exposure to IL-4 and IL-13. Basolateral exposure of epithelial monolayers to both IL-4 and IL-13 attenuated epithelial barrier function and increased paracellular flux of a dextran marker by greater than 65% in a dose- and time-dependent fashion. Stimulated Cl- secretion, as measured by epithelial short circuit current, however, was diminished only by IL-4 and not IL-13, demonstrating cytokine specificity in this epithelial function. Decreased Cl- secretion following IL-4 exposure was associated with diminished Cl- channel activity and IL-4 pretreatment of epithelia decreased expression of the cystic fibrosis transmembrane regulator. Finally, stimulated fluid transport across cultured epithelia was diminished following exposure to IL-4, but not IL-13. These results indicate that while post-receptor signaling events induced by IL-13 and IL-4 may be similar, end point function is cytokine-specific. INTRODUCTIONEpithelial cells of the intestine are uniquely positioned to serve as a direct line of communication between the immune system and the external environment. Intestinal epithelial surfaces are continuously exposed on the luminal side to foreign antigens and a myriad of microorganisms, while at the same time, intimately associated with the immune system via subepithelial lymphoid tissue. In the basal state, and especially during disease flares, lymphocyte-derived cytokines are readily detectable in the mucosa(1.Quiding M. Nordstrom I. Kilander A. Andersson G. Hanson L.A. Holmgren J. Czerkinsky C. J. Clin. Invest. 1991; 88: 143-148Crossref PubMed Scopus (192) Google Scholar). For most cytokines, target cell function is pleiotropic, and individual cytokines may act singly, additively, antagonistically, or synergistically(2.Kishimoto T. Taga T. Akira S. Cell. 1994; 76: 253-262Abstract Full Text PDF PubMed Scopus (1243) Google Scholar). Previous studies have demonstrated that intestinal epithelia bear functional receptors for a number of diverse cytokines, including but not limited to IFN-γ( 1The abbreviations used are: IFN-γinterferon-γIL-4interleukin-4IL-13interleukin-13IBMX3-isobutyl-1-methylxanthineCFTRcystic fibrosis transmembrane regulatorANOVAanalysis of variance.) (3.Colgan S.P. Parkos C.A. Delp C. Arnaout M.A. Madara J.L. J. Cell Biol. 1993; 120: 785-795Crossref PubMed Scopus (145) Google Scholar, 4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar, 5.Madara J.L. Stafford J. J. Clin. Invest. 1989; 83: 724-727Crossref PubMed Scopus (640) Google Scholar), IL-2(6.Ciacci C. Mahida Y.R. Dignass A. Koizumi M. Podolsky D.K. J. Clin. Invest. 1993; 92: 527-532Crossref PubMed Scopus (95) Google Scholar), IL-4(7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar), IL-13 (8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar), tumor necrosis factor-α(9.Mullin J.M. Snock K.V. Cancer Res. 1990; 50: 2172-2179PubMed Google Scholar), transforming growth factor-β(10.Kurokawa M. Lynch K. Podolsky D.K. Biochem. Biophys. Res. Commun. 1987; 142: 775-782Crossref PubMed Scopus (261) Google Scholar, 11.Barnard J.A. Beauchamp R. Coffey R.J. Moses H.L. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 1578-1582Crossref PubMed Scopus (316) Google Scholar), and hepatocyte growth factor(12.Nusrat A. Parkos C.A. Bacarra A.E. Godowski P.J. Delp-Archer C. Rosen E.M. Madara J.L. J. Clin. Invest. 1994; 93: 2056-2065Crossref PubMed Scopus (199) Google Scholar).Interleukin-13 is a recently described cytokine produced by activated T lymphocytes(13.McKenzie A.N.J. Culpepper J.A. de Waal Malefyt R. Briere F. Punnonen J. Aversa G. Sato A. Cocks B.G. Menon S. deVries J.E. Banchereau J. Zurawski G. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3735-3740Crossref PubMed Scopus (530) Google Scholar). IL-13 and IL-4 share a number of biological responses when exposed to monocytes, macrophages, and B cells(14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar). We have recently demonstrated that IL-13, like IL-4, increases paracellular permeability of cultured intestinal epithelial monolayers(8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar). In addition, human intestinal epithelial cells posess IL-4 receptors(16.Reinecker H.C. Podolsky D.K. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8353-8357Crossref PubMed Scopus (144) Google Scholar), and while IL-13 does not bind to the IL-4 receptor, others have proposed overlapping signal transduction pathways(14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar). The genes for IL-13 and IL-4 are closely linked in both humans and mice, and these cytokines are approximately 30% homologous (17.Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemot J.-C. Kadhad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty B. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (841) Google Scholar) (approximately the same degree of homology as IL-1α and IL-β(18.Eisenberg S.P. Evans R.J. Arend W.P. Nature. 1990; 343: 341-346Crossref PubMed Scopus (919) Google Scholar)).In this study, we demonstrate strict cytokine specificity of IL-4 and IL-13 actions on epithelial ion transport. While both IL-13 and IL-4 specifically diminish epithelial barrier function, only IL-4 attenuates epithelial electrogenic Cl- secretion (the transport event underlying hydration of mucosal surfaces), indicating cytokine specificity. Such decreases in Cl- secretion by IL-4 are attributable to diminished Cl- channel activity and associated with IL-4-mediated down-regulation of CFTR protein expression. These results suggest that, while the intracellular signaling events induced by IL-13 and IL-4 reportedly exhibit many similarities, the resulting end point phenotype of epithelial function demonstrates clear specificities between these cytokines. Such observations indicate that differences in IL-13 and IL-4 signal transduction pathways exist.MATERIALS AND METHODSCell CultureConfluent monolayers of the human intestinal cell line T84 were grown on collagen-coated permeable supports and maintained until steady-state transepithelial resistance was achieved. To measure agonist-stimulated short circuit currents, transepithelial potentials, and resistance, a commercially available voltage clamp (Iowa Dual Voltage Clamps, Bioengineering, University of Iowa) interfaced with an equilibrated pair of calomel electrodes and a pair of Ag-AgCl electrodes was utilized, as described in detail elsewhere (19.Dharmsathaphorn K. Madara J.L. Methods Enzymol. 1990; 192: 354-389Crossref PubMed Scopus (153) Google Scholar). Using these values and Ohm's law (V = IR), tissue resistance and transepithelial current were calculated. Fluid resistance within the system accounts for less than 5% of total transepithelial resistance. Hanks' balanced salt solution was used in both apical and basolateral baths during all experiments, unless otherwise noted. Assessment of paracellular flux of fluorescein isothiocyanate-labeled dextran (molecular mass: 10 kDa, Molecular Probes, Eugene, OR) was performed exactly as described before(8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar). All experiments were performed in a 37°C room to ensure that epithelial monolayers, solutions, plastic ware, etc. were maintained at uniform 37°C temperature. Tissue culture supplies were obtained from Life Technologies, Inc. and Costar (Cambridge, MA). Recombinant human IL-13 was a kind gift from Dr. Satish Menon at DNAX Research Institute (Palo Alto, CA), recombinant human IL-4 and was purchased from R& Systems (Minneapolis, MN), and recombinant human IFN-γ was a kind gift from Genentech (South San Francisco, CA). Other reagents were obtained from Sigma or Calbiochem.T84 epithelial monolayers were exposed to cytokines at indicated concentrations for indicated periods of time. Unless otherwise noted, monolayers were exposed to cytokine on both apical and basolateral surfaces. All incubations included controls consisting of media alone.Lactate Dehydrogenase Release AssayT84 intestinal epithelial monolayers were grown on 96-well plates with and without addition of cytokine for 48 h. Cytotoxicity as determined by lactate dehydrogenase release was measured color metrically (Cytotox 96(™) non-radioactive cytotoxicity assay, Promega, Madison, WI) according to the manufacturer's protocol.Fluid Transport AssayThe methods for measuring transmonolayer fluid movement were adapted from those described by Smith and Welsh(20.Smith J.J. Welsh M.J. J. Clin. Invest. 1993; 91: 1590-1597Crossref PubMed Scopus (69) Google Scholar). T84 monolayers were exposed to indicated cytokines for 24 h. To measure net fluid movement, the apical solution was replaced with 100 μl of media and layered with 1 ml of warm, sterile mineral oil to minimize evaporation. Others have shown that it is necessary to begin the experiment with a small amount of fluid (i.e. 100 μl) so as to recover enough for analysis. Coating monolayers with mineral oil does not alter transport properties (20.Smith J.J. Welsh M.J. J. Clin. Invest. 1993; 91: 1590-1597Crossref PubMed Scopus (69) Google Scholar). In some monolayers, the cAMP agonists forskolin (50 μM) and 3-isobutyl-1-methylxanthine (IBMX, 100 μM) were added to the basolateral solution to promote fluid movement. After an additional 24 h (total exposure to cytokine, 48 h), the apical solution was collected, spun at high speed in an Eppendorf centrifuge, and the recovered fluid was weighed on a balance.125I Efflux AssaysCl- channel activity was monitored using 125I efflux assays with T84 cells grown on 1-cm2 permeable supports, as described before(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar, 21.Venglarik C.J. Bridges R.J. Frizzell R.A. Am. J. Physiol. 1990; 259: C358-C362Crossref PubMed Google Scholar). Rate constants of efflux were calculated as [ln(R2) - ln(R1)]/(t2 - t1), where Rx is the percent of radioactivity remaining monolayer-associated at time tx, as reported elsewhere(21.Venglarik C.J. Bridges R.J. Frizzell R.A. Am. J. Physiol. 1990; 259: C358-C362Crossref PubMed Google Scholar).CFTR ImmunoprecipitationT84 cells were grown on 5-cm2 permeable supports in the presence or absence (media alone) of the indicated cytokines. Immunoprecipitation was performed using a mouse anti-human CFTR monoclonal antibody (Genzyme Corp., Cambridge, MA) as described previously(22.Gregory R.J. Cheng S.H. Rich D.P. Marshall J. Paul S. Hehir K. Ostedgaard L. Klinger K.W. Welsh M.J. Smith A.E. Nature. 1990; 347: 382-386Crossref PubMed Scopus (269) Google Scholar). CFTR was in vitro phosphorylated by incubating immunoprecipitates with protein kinase A (20 ng/ml, Sigma) and 10 μCi [γ-32P]ATP in 50 μl of kinase buffer (50 mM Tris-HCl (pH 7.5), 10 mM MgCl2, and 100 μg/ml bovine serum albumin) at 30°C for 60 min as described previously(22.Gregory R.J. Cheng S.H. Rich D.P. Marshall J. Paul S. Hehir K. Ostedgaard L. Klinger K.W. Welsh M.J. Smith A.E. Nature. 1990; 347: 382-386Crossref PubMed Scopus (269) Google Scholar). Bands at ~165 kDa consistent with previously published CFTR from resulting autoradiograms were analyzed from scanned images using National Institutes of Health Image software (Bethesda, MD).Statistical AnalysisTransepithelial resistance's were compared by Student's t test. Time course data and dose responses were compared by analysis of variance (ANOVA) for significance. All results are presented as the mean and S.E. of n experiments.RESULTSFunctionally Defined IL-13 Receptors on T84 Intestinal Epithelial CellsAs we have shown previously, intestinal epithelial exposure to IL-4 (7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar, 8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar) or IL-13 (8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar) exhibits a marked attenuation in transepithelial resistance and concomitant increases in paracellular permeability of labeled tracers. Thus, transepithelial resistance was used as a screening assay for cytokine bioactivity in this system. As shown in Fig. 1A, addition of IL-4 or IL-13 to confluent T84 cells for 48 h resulted in a dose-dependent decrease in epithelial barrier function (both p < 0.001 compared with media alone control, ANOVA). Efficacy was comparable between IL-4 and IL-13 (EC50: ~1.5 ng/ml for both). Predictably, and as we have shown before(8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar), paracellular flux of 10 kDa (Stokes radius: 23 Å) fluorescein isothiocyanate-dextran was increased for both IL-13 and IL-4 compared with media alone controls (flux of 3.7 ± 0.81, 11.9 ± 1.54, 10.9 ± 2.01 pM/cm2•h for media controls, IL-13- and IL-4-exposed monolayers (10 ng/ml, 48 h), respectively (p < 0.01 for IL-13 and IL-4 compared with control). Time course experiments (range 12-72 h, 10 ng/ml) and subsequent assessment of barrier function resulted in no distinguishable difference between IL-4 and IL-13 (t1/2 ~30 h for both IL-13 and IL-4, data not shown). Such results are not explained by IL-4 toxicity (7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar) or by IL-13 toxicity (spontaneous lactate dehydrogenase release measured over a 48-h period was equivalent for control monolayers and monolayers exposed to IL-13, data not shown). IL-13, like IL-4(7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar), appeared to signal via a basolaterally restricted receptor. Using monolayers grown on permeable supports, basolateral pre-exposure to IL-13 (10 ng/ml, 48 h) elicited a 72 ± 8.5% fall in transepithelial resistance (p < 0.01 compared with media alone), while apical exposure to this cytokine failed to significantly influence resistance (6 ± 3.1% decrease compared with media alone, p > 0.05). Finally, exposure of T84 cells to a combination of IL-13 and IL-4 at approximate EC50 (final concentration alone or in combination 2.5 ng/ml, 48 h) did not result in additive effects on barrier function (45 ± 9.7, 47 ± 6.5, and 53 ± 7.2% fall in transepithelial resistance compared with media alone controls for IL-4 alone, IL-13 alone, and IL-4/IL-13 combined, respectively). These data indicate that IL-4 and IL-13 share many properties with regard to regulation of epithelial barrier function defects and may result from overlapping signal transduction pathways.Selective Down-regulation of Electrogenic Cl- Secretion by IL-4 and Not IL-13As shown in Fig. 1B, and as we have demonstrated previously(7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar), IL-4 attenuates stimulated electrogenic Cl- secretion (measured as short circuit current, Isc), the ion transport event responsible for mucosal hydration(23.Powell D.W. Johnson L.R. Physiology of the Gastrointestinal Tract. Raven Press, New York1987: 1267-1291Google Scholar). However, a clear discrepancy between IL-4 and IL-13 was evident at this level of epithelial function. Indeed, while IL-4 dose-dependently attenuated forskolin-stimulated Isc (p < 0.001, ANOVA), no significant reduction was apparent at equivalent concentrations of IL-13 (p = not significant, ANOVA). As shown in Fig. 2A, a significant shift in the dose response to stimulation by the cAMP agonist forskolin (range 0.01-10 μM) was evident following epithelial exposure to IL-4 (10 ng/ml, 48 h, two-factor ANOVA, p < 0.025), but not to IL-13 (10 ng/ml, 48 h, two-factor ANOVA, p = not significant). Baseline transepithelial resistances of these monolayers revealed an IL-13 effect (615 ± 119 ohm-cm2) as well as an IL-4 effect (559 ± 97 ohm-cm2) compared with no cytokine controls (1543 ± 219 ohm-cm2), indicating cytokine selectivity in cAMP-stimulated Cl- secretion. Similarly, Ca2+-mediated Cl- secretion (using carbachol, Fig. 2B) was attenuated by IL-4 (two-factor ANOVA, p < 0.01 compared with no cytokine controls), but no demonstrable decrease was apparent using IL-13 (two-factor ANOVA, p = not significant compared with no cytokine controls). Last, the ED50 for IL-4-mediated attenuation of Cl- secretion was comparable with that for IL-4 influences on barrier function (2.5 versus 1.5 ng/ml, respectively), indicating that these two functional consequences of IL-4 exposure were likely consequent to the same ligand-receptor binding event.Figure 2:Only IL-4 diminishes cAMP and Ca2+-mediated electrogenic chloride secretion. T84 intestinal epithelial monolayers were exposed to media alone (CTL, open squares), human recombinant IL-4 (open circles), or human recombinant IL-13 (closed circles) at 5 ng/ml for 48 h. Shown here are dose-response curves for epithelial stimulation of Cl- secretion (measured as short circuit current, Isc) by the cAMP-mediated agonist forskolin (top panel) or the Ca2+-mediated agonist carbachol (bottom panel). Transepithelial resistance and Isc were measured by standard methods (see “Materials and Methods”). Data are pooled from six to nine individual monolayers in each condition, and results are expressed as the mean ± S.E. peak Isc.View Large Image Figure ViewerDownload Hi-res image Download (PPT)This IL-4-induced decrease in Cl- secretion cannot be competed by excess IL-13. Experiments were performed in which 10- and 100-fold excess concentrations of IL-13 (50 and 500 ng/ml, respectively, 48 h) were added to IL-4 treated (5 ng/ml, 48 h) monolayers and assayed for forskolin-stimulated (1 μM final concentration) Cl- secretion. Indeed compared with no cytokine control, addition of IL-4 alone decreased Cl- secretion by 65 ± 10% (Isc of 58 ± 8.6 and 20 ± 6.2 for control and IL-4 treated, respectively, p < 0.01), while no competitive effect was observed with addition of 50 ng/ml IL-13 (Isc of 22 ± 7.1, p = not significant compared with IL-4 alone) or 500 ng/ml IL-13 (Isc of 25 ± 6.6, p = not significant compared with IL-4 alone).IL-4 Down-regulates Cl- Channel ActivityAttenuation of Cl- secretion, such as that shown above for IL-4 exposure, but not for IL-13, might relate to a variety of cytokine-elicited influences in cell function, the most direct of which would be down-regulated activity/expression of the Cl- channel itself. Thus, we next examined whether differences between IL-4 and IL-13 were apparent at the epithelial Cl- channel. The rate constant of 125I efflux was used to estimate forskolin-stimulated activation of Cl- channel on permeable support grown monolayers of T84 epithelial cells with and without exposure to cytokine. This method has been validated as a reliable measurement of Cl- efflux from T84 epithelial cells(21.Venglarik C.J. Bridges R.J. Frizzell R.A. Am. J. Physiol. 1990; 259: C358-C362Crossref PubMed Google Scholar). As shown in Fig. 3, pre-exposure of epithelial monolayers to IL-4 significantly decreased forskolin-stimulated 125I efflux from T84 monolayers (two-factor ANOVA, p < 0.01 compared with media alone), while no significant effects were observed in response to IL-13 (two-factor ANOVA, p = not significant compared with media alone). As a positive control for attenuated Cl- channel activity(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar), monolayers were exposed to IFN-γ (1000 units/ml, 48 h). Unstimulated efflux rate constants for 125I were not different for monolayers exposed to IL-4, IL-13, or IFN-γ (data not shown) compared with untreated controls (Fig. 3). These data demonstrate that IL-4, like IFN-γ(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar), diminishes stimulated Cl- channel activity, while IL-13 does not.Figure 3:IL-4 diminishes apical chloride channel activity. T84 intestinal epithelial monolayers were exposed to media alone (open circles), human recombinant IL-4 (closed squares, 5 ng/ml), IL-13 (closed circles, 5 ng/ml), or IFN-γ (open squares, 1000 units/ml) for 48 h. Shown here are sequential 1-min rate constants of 125I efflux from T84 cells, as calculated by Venglarik et al.(21.Venglarik C.J. Bridges R.J. Frizzell R.A. Am. J. Physiol. 1990; 259: C358-C362Crossref PubMed Google Scholar). After two 1-min washout periods, forskolin (5 μM final concentration) was added, and 125I efflux was assayed in sequential 1-min periods. In some monolayers (no agonist, closed triangles) no forskolin was added. Data are pooled from four to six monolayers each, and results are expressed as the mean ± S.E.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Influence of IL-13/IL-4 on Epithelial Expression of CFTRT84 cells, as do native intestinal Cl- secreting cells, express the CFTR, a protein that serves as both a Cl- channel and a Cl- channel regulator(24.Al-Awquati Q. Science. 1995; 269: 805-806Crossref PubMed Scopus (174) Google Scholar). Thus, we determined whether decreased CFTR expression contributed to attenuated Cl- secretion and Cl- channel activity in T84 cells following exposure to IL-13 or IL-4. CFTR was detected in T84 cell lysates by adding [γ-32P]ATP and protein kinase A to immunoprecipitates formed using monoclonal antibodies raised against CFTR (Fig. 4A). Pre-exposure of T84 cell monolayers to IL-4 resulted in decreased CFTR protein levels, similar to our positive control IFN-γ (Fig. 4, A and B), as others have shown(25.Bensancon F. Przewlocki G. Baro I. Hongre A.-S. Escande D. Edelman A. Am. J. Physiol. 1994; 267: C1398-C1404Crossref PubMed Google Scholar). Consistent with our results above, no differences were observed between IL-13 and media only controls at the level of CFTR.Figure 4:IL-4 diminishes immunoprecipitable CFTR protein levels. T84 epithelial monolayers were exposed to media alone, human recombinant IL-4 (10 ng/ml, 48 h), IL-13 (10 ng/ml), or IFN-γ (1000 units/ml, 48 h). Phosphorylated immunoprecipitates were derived from equivalent numbers of T84 cells using anti-CFTR monoclonal antibody. Protein samples were separated under reducing conditions on a 7% polyacrylamide SDS gel. A shows resulting blots from immunoprecipitation. B depicts densitometry tracings from immunoprecipitated bands shown in A. One of two experiments are represented.View Large Image Figure ViewerDownload Hi-res image Download (PPT)Impact of IL-4/IL-13 on Fluid Transport Intestinal EpitheliaThe key end point of epithelial electrogenic Cl- secretion is net transepithelial secretion of isosmotic fluid. Thus, we examined whether IL-4 induced decreased fluid transport across epithelial monolayers and, as suggested by the above results, whether differences between IL-4 and IL-13 exist at this level. As shown in Fig. 5, base-line (i.e. unstimulated) fluid transport was negligible and did not differ between cells exposed to media, IL-4, IL-13, or IFN-γ. However, in the presence of the cAMP agonists forskolin (50 μM) and IBMX (100 μM) for 24 h, a marked difference between IL-4 and IL-13 was observed (Fig. 5). Indeed, epithelial exposure to IL-4 significantly attenuated fluid movement across epithelia (p < 0.01 compared with media only control) in a manner similar to IFN-γ (p < 0.001 compared with media only). Monolayers exposed to IL-13, however, were not different than media only controls (p = not significant), indicating that IL-4 and IL-13 also differentially regulate the net result of electrogenic Cl- secretion: isosmotic fluid secretion.Figure 5:IL-4 diminishes fluid transport across cultured T84 epithelial cells. T84 epithelial monolayers were exposed to media alone, human recombinant IL-4 (10 ng/ml, 48 h), IL-13 (10 ng/ml), or IFN-γ (1000 units/ml, 48 h). After 24 h, cells were stimulated (+cAMP, open bars) or not stimulated (-cAMP, closed bars) with the cAMP agonist forskolin (50 μM final concentration) in the presence of the phophodiesterase inhibitor IBMX (100 μM final concentration). The dashed line indicates the initial volume of fluid on the mucosal surface. Values represent the recovered fluid volume after 24 h. Data are pooled from six to eight monolayers each, and results are expressed as the mean ± S.E.View Large Image Figure ViewerDownload Hi-res image Download (PPT)DISCUSSIONSoluble factors produced by lymphocytes adjacent to the epithelium modulate epithelial function. We and others have demonstrated that a diverse array of cytokines regulate the function of model intestinal epithelia(3.Colgan S.P. Parkos C.A. Delp C. Arnaout M.A. Madara J.L. J. Cell Biol. 1993; 120: 785-795Crossref PubMed Scopus (145) Google Scholar, 5.Madara J.L. Stafford J. J. Clin. Invest. 1989; 83: 724-727Crossref PubMed Scopus (640) Google Scholar, 26.Holmgren J. Fryklund J. Larsson H. Scand. J. Immunol. 1989; 30: 499-503Crossref PubMed Scopus (57) Google Scholar, 27.Adams R.B. Planchon S.M. Roche J.K. J. Immunol. 1993; 150: 2356-2363PubMed Google Scholar). Here we use polarized model intestinal epithelia, which demonstrate readily detectable biophysical responses as a means to probe potential differences in IL-4- and IL-13-mediated signal transduction pathways. Our results indicate that both IL-4 and IL-13, which share many biological properties in a variety of systems (14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar), attenuate epithelial barrier function; IL-4 selectively down-regulates electrogenic Cl- secretion, indicating distinct cytokine specificity. In addition, these studies reveal that IL-4 attenuation of Cl- secretion, which we have observed previously(7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar), occurs through regulation of expression of the apical Cl- efflux channel and results in diminished epithelial fluid secretion.IL-13 is a recently described cytokine that is secreted by activated T lymphocytes and shares many properties with IL-4(14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar). To date, functional IL-13 receptors have been demonstrated on monocyte/macrophages, B cells, NK cells, mast cells, fibroblasts, renal epithelia, and intestinal epithelia(8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar, 14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar, 28.Vita N. Lefort S. Laurent P. Capu D. Ferrara P. J. Biol. Chem. 1995; 270: 3512-3517Abstract Full Text Full Text PDF PubMed Scopus (94) Google Scholar, 29.Riemann D. Kehlen A. Langner J. Clin. Exp. Immunol. 1995; 100: 277-283Crossref PubMed Scopus (55) Google Scholar). In general, mucosal lymphocytes are subdivided into two populations, intraepithelial lymphocytes and lamina propria lymphocytes, each defined by their spatial proximity to the epithelia and each with characteristic surface markers and cytokine production patterns. The primary source of IL-13 and IL-4 appears to be the lamina propria lymphocyte population of CD4+, Th-0, Th-1, or Th-2 T-cells, although other cell types may also produce these cytokines(14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar). The present study demonstrates that in a time- and dose-dependent manner, exogenous exposure of intestinal epithelial monolayers to IL-13 diminishes barrier function (measured as transepithelial resistance and paracellular flux), an essential and primary role of mucosal epithelial cells(30.Powell D. Am. J. Physiol. 1981; 241: G275-G288PubMed Google Scholar). The functional IL-13 receptor is localized to the basolateral surface on T84 cells. This feature of diminished barrier following ligation of the IL-13 receptor on T84 cells resembles that of IL-4 (7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar) and IFN-γ(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar, 5.Madara J.L. Stafford J. J. Clin. Invest. 1989; 83: 724-727Crossref PubMed Scopus (640) Google Scholar). At present, a commonality between these cytokines and modulation of epithelial barrier has not been identified.The structure of the IL-13 receptor has remained elusive. While IL-13 does not bind to the IL-4 receptor, it has been shown that IL-13 can inhibit the binding of labeled IL-4 to cells that are responsive to both cytokines(31.Zurawski S.M. Vega F.J. Huyghe B. Zurawski G. EMBO J. 1993; 12: 2663-2670Crossref PubMed Scopus (439) Google Scholar), and thus it has been proposed that the IL-13 receptor shares a component of the IL-4 receptor important in signal transduction. Of note on this accord, Reinecker and Podolsky (16.Reinecker H.C. Podolsky D.K. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8353-8357Crossref PubMed Scopus (144) Google Scholar) recently demonstrated that intestinal epithelia possess transcripts for and signal transduction capacity (tyrosine phosphorylation) for a number of cytokines that share the IL-2 receptor γc chain, including the IL-4 receptor. Alternatively, the IL-4 and IL-13 receptors may share redundant signal transduction pathways. We demonstrate that addition of IL-13 in combination with IL-4 at approximate ED50 does not result in additive or synergistic effects on diminished transepithelial resistance. Moreover, addition of even 100-fold excess exogenous IL-13 failed to inhibit IL-4-elicited diminution of Cl- secretion (see “Results”), indicating that it is unlikely IL-4 and IL-13 bind to the same receptor, or if this is the case, receptor affinities favor binding of IL-4 to a great extent. Finally, it is worthwhile to note that we have not examined whether IL-4 and/or IL-13 might liberate epithelial-derived cytokines that could act through autocrine mechanisms to regulate such functions as barrier and ion transport. Further work on IL-13 receptor binding should reveal important information regarding the mechanism by which this cytokine regulates epithelial function.While a number of studies have demonstrated that IL-4 and IL-13 share many biological properties, the present studies clearly demonstrate differences between IL-4 and IL-13 at the level of epithelial electrogenic Cl- secretion, the transport event responsible for mucosal hydration(23.Powell D.W. Johnson L.R. Physiology of the Gastrointestinal Tract. Raven Press, New York1987: 1267-1291Google Scholar). Here we show that IL-4 selectively down-regulates Cl- transport. Such down-regulation was evident in response to both cAMP (forskolin) and Ca2+ (carbachol)-stimulated Cl- secretion, was observed at the level of apical Cl- channel activity, and resulted in decreased transmonolayer fluid movement. Additionally, diminished levels of the CFTR were associated with IL-4 pre-exposure. Whether such decreases in CFTR (~65%) result in our observed decrease in Cl- secretion are not known at the present time. Another possible explanation for diminished Cl- secretion in response to IL-4 is attenuation of basal K+ efflux pathways. Current methods available to study K+ channel activity lack the sensitivity necessary to detect decrements that might be induced by IL-4, and thus, we have not directly examined basal K+ channel activity in T84 cells.Such findings with IL-4 are remarkably similar to previous investigations using IFN-γ, including diminished epithelial barrier (3.Colgan S.P. Parkos C.A. Delp C. Arnaout M.A. Madara J.L. J. Cell Biol. 1993; 120: 785-795Crossref PubMed Scopus (145) Google Scholar, 4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar, 5.Madara J.L. Stafford J. J. Clin. Invest. 1989; 83: 724-727Crossref PubMed Scopus (640) Google Scholar), decreased electrogenic Cl- secretion in response to a variety of agonists(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar), decreased Cl- channel activity(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar), and decreased CFTR protein(25.Bensancon F. Przewlocki G. Baro I. Hongre A.-S. Escande D. Edelman A. Am. J. Physiol. 1994; 267: C1398-C1404Crossref PubMed Google Scholar). We have defined such IFN-γ-elicited changes as a “cell surface phenotype switch,” in which epithelia exposed to such stimuli lose many epithelial characteristics and assume other more immune accessory cell-like features (increased major histocompatibility class I and II expression, regulated neutrophil trafficking, etc.)(4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar). Such results suggest that a T-cell-derived cytokines specifically modulate the extent of electrolyte and water loss across the intestinal barrier, a hypothesis that has been proposed previously for IFN-γ(26.Holmgren J. Fryklund J. Larsson H. Scand. J. Immunol. 1989; 30: 499-503Crossref PubMed Scopus (57) Google Scholar).In summary, these data show that a human intestinal crypt epithelial model has diverse functional characteristics modulated by IL-4 and IL-13 exposure to the basolateral surface. Furthermore, end point functions elicited by IL-4 and IL-13 on intestinal epithelial biology are distinct. Such observations strengthen the hypothesis that local mucosal cytokine profiles will contribute significantly to the regulation of epithelial barrier function and ion transport characteristics. INTRODUCTIONEpithelial cells of the intestine are uniquely positioned to serve as a direct line of communication between the immune system and the external environment. Intestinal epithelial surfaces are continuously exposed on the luminal side to foreign antigens and a myriad of microorganisms, while at the same time, intimately associated with the immune system via subepithelial lymphoid tissue. In the basal state, and especially during disease flares, lymphocyte-derived cytokines are readily detectable in the mucosa(1.Quiding M. Nordstrom I. Kilander A. Andersson G. Hanson L.A. Holmgren J. Czerkinsky C. J. Clin. Invest. 1991; 88: 143-148Crossref PubMed Scopus (192) Google Scholar). For most cytokines, target cell function is pleiotropic, and individual cytokines may act singly, additively, antagonistically, or synergistically(2.Kishimoto T. Taga T. Akira S. Cell. 1994; 76: 253-262Abstract Full Text PDF PubMed Scopus (1243) Google Scholar). Previous studies have demonstrated that intestinal epithelia bear functional receptors for a number of diverse cytokines, including but not limited to IFN-γ( 1The abbreviations used are: IFN-γinterferon-γIL-4interleukin-4IL-13interleukin-13IBMX3-isobutyl-1-methylxanthineCFTRcystic fibrosis transmembrane regulatorANOVAanalysis of variance.) (3.Colgan S.P. Parkos C.A. Delp C. Arnaout M.A. Madara J.L. J. Cell Biol. 1993; 120: 785-795Crossref PubMed Scopus (145) Google Scholar, 4.Colgan S.P. Parkos C.A. Matthews J.B. D'Andrea L. Awtrey C.S. Lichtman A. Delp C. Madara J.L. Am. J. Physiol. 1994; 267: 402-410Crossref PubMed Google Scholar, 5.Madara J.L. Stafford J. J. Clin. Invest. 1989; 83: 724-727Crossref PubMed Scopus (640) Google Scholar), IL-2(6.Ciacci C. Mahida Y.R. Dignass A. Koizumi M. Podolsky D.K. J. Clin. Invest. 1993; 92: 527-532Crossref PubMed Scopus (95) Google Scholar), IL-4(7.Colgan S.P. Resnick M.B. Parkos C.A. Delp-Archer C. Bacarra A.E. Weller P.F. Madara J.L. J. Immunol. 1994; 153: 2122-2129PubMed Google Scholar), IL-13 (8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar), tumor necrosis factor-α(9.Mullin J.M. Snock K.V. Cancer Res. 1990; 50: 2172-2179PubMed Google Scholar), transforming growth factor-β(10.Kurokawa M. Lynch K. Podolsky D.K. Biochem. Biophys. Res. Commun. 1987; 142: 775-782Crossref PubMed Scopus (261) Google Scholar, 11.Barnard J.A. Beauchamp R. Coffey R.J. Moses H.L. Proc. Natl. Acad. Sci. U. S. A. 1989; 86: 1578-1582Crossref PubMed Scopus (316) Google Scholar), and hepatocyte growth factor(12.Nusrat A. Parkos C.A. Bacarra A.E. Godowski P.J. Delp-Archer C. Rosen E.M. Madara J.L. J. Clin. Invest. 1994; 93: 2056-2065Crossref PubMed Scopus (199) Google Scholar).Interleukin-13 is a recently described cytokine produced by activated T lymphocytes(13.McKenzie A.N.J. Culpepper J.A. de Waal Malefyt R. Briere F. Punnonen J. Aversa G. Sato A. Cocks B.G. Menon S. deVries J.E. Banchereau J. Zurawski G. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3735-3740Crossref PubMed Scopus (530) Google Scholar). IL-13 and IL-4 share a number of biological responses when exposed to monocytes, macrophages, and B cells(14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar). We have recently demonstrated that IL-13, like IL-4, increases paracellular permeability of cultured intestinal epithelial monolayers(8.Sanders S.E. Madara J.L. McGuirk D.K. Gelman D.S. Colgan S.P. Epithelial Cell Biol. 1995; 4: 25-34PubMed Google Scholar). In addition, human intestinal epithelial cells posess IL-4 receptors(16.Reinecker H.C. Podolsky D.K. Proc. Natl. Acad. Sci. U. S. A. 1995; 92: 8353-8357Crossref PubMed Scopus (144) Google Scholar), and while IL-13 does not bind to the IL-4 receptor, others have proposed overlapping signal transduction pathways(14.Zurawski G. deVries J.E. Stem Cells. 1995; 100: 169-174Google Scholar, 15.Zurawski G. deVries J.E. Immunol. Today. 1994; 15: 19-26Abstract Full Text PDF PubMed Scopus (837) Google Scholar). The genes for IL-13 and IL-4 are closely linked in both humans and mice, and these cytokines are approximately 30% homologous (17.Minty A. Chalon P. Derocq J.-M. Dumont X. Guillemot J.-C. Kadhad M. Labit C. Leplatois P. Liauzun P. Miloux B. Minty B. Casellas P. Loison G. Lupker J. Shire D. Ferrara P. Caput D. Nature. 1993; 362: 248-250Crossref PubMed Scopus (841) Google Scholar) (approximately the same degree of homology as IL-1α and IL-β(18.Eisenberg S.P. Evans R.J. Arend W.P. Nature. 1990; 343: 341-346Crossref PubMed Scopus (919) Google Scholar)).In this study, we demonstrate strict cytokine specificity of IL-4 and IL-13 actions on epithelial ion transport. While both IL-13 and IL-4 specifically diminish epithelial barrier function, only IL-4 attenuates epithelial electrogenic Cl- secretion (the transport event underlying hydration of mucosal surfaces), indicating cytokine specificity. Such decreases in Cl- secretion by IL-4 are attributable to diminished Cl- channel activity and associated with IL-4-mediated down-regulation of CFTR protein expression. These results suggest that, while the intracellular signaling events induced by IL-13 and IL-4 reportedly exhibit many similarities, the resulting end point phenotype of epithelial function demonstrates clear specificities between these cytokines. Such observations indicate that differences in IL-13 and IL-4 signal transduction pathways exist." @default.
• W2026499711 created "2016-06-24" @default.
• W2026499711 creator A5023229653 @default.
• W2026499711 creator A5049650132 @default.
• W2026499711 creator A5049715883 @default.
• W2026499711 creator A5066802872 @default.
• W2026499711 creator A5079112929 @default.
• W2026499711 date "1996-03-01" @default.
• W2026499711 modified "2023-09-27" @default.
• W2026499711 title "Interleukin-4 and Interleukin-13 Differentially Regulate Epithelial Chloride Secretion" @default.
• W2026499711 cites W1515675646 @default.
• W2026499711 cites W151793644 @default.
• W2026499711 cites W1582077381 @default.
• W2026499711 cites W1932880974 @default.
• W2026499711 cites W1959459432 @default.
• W2026499711 cites W1989459539 @default.
• W2026499711 cites W2008577129 @default.
• W2026499711 cites W2011257622 @default.
• W2026499711 cites W2036774130 @default.
• W2026499711 cites W2037484815 @default.
• W2026499711 cites W2039258037 @default.
• W2026499711 cites W2057626594 @default.
• W2026499711 cites W2058120223 @default.
• W2026499711 cites W2062811687 @default.
• W2026499711 cites W2065367851 @default.
• W2026499711 cites W2095127706 @default.
• W2026499711 cites W2098778559 @default.
• W2026499711 cites W2100683309 @default.
• W2026499711 cites W2101173615 @default.
• W2026499711 cites W2148072223 @default.
• W2026499711 cites W2148320132 @default.
• W2026499711 cites W2148510796 @default.
• W2026499711 cites W2156644464 @default.
• W2026499711 cites W2160648984 @default.
• W2026499711 cites W2415195951 @default.
• W2026499711 cites W2418960803 @default.
• W2026499711 doi "https://doi.org/10.1074/jbc.271.13.7460" @default.
• W2026499711 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8631774" @default.
• W2026499711 hasPublicationYear "1996" @default.
• W2026499711 type Work @default.
• W2026499711 sameAs 2026499711 @default.
• W2026499711 citedByCount "126" @default.
• W2026499711 countsByYear W20264997112012 @default.
• W2026499711 countsByYear W20264997112013 @default.
• W2026499711 countsByYear W20264997112014 @default.
• W2026499711 countsByYear W20264997112015 @default.
• W2026499711 countsByYear W20264997112016 @default.
• W2026499711 countsByYear W20264997112017 @default.
• W2026499711 countsByYear W20264997112018 @default.
• W2026499711 countsByYear W20264997112019 @default.
• W2026499711 countsByYear W20264997112020 @default.
• W2026499711 countsByYear W20264997112021 @default.
• W2026499711 countsByYear W20264997112022 @default.
• W2026499711 countsByYear W20264997112023 @default.
• W2026499711 crossrefType "journal-article" @default.
• W2026499711 hasAuthorship W2026499711A5023229653 @default.
• W2026499711 hasAuthorship W2026499711A5049650132 @default.
• W2026499711 hasAuthorship W2026499711A5049715883 @default.
• W2026499711 hasAuthorship W2026499711A5066802872 @default.
• W2026499711 hasAuthorship W2026499711A5079112929 @default.
• W2026499711 hasBestOaLocation W20264997111 @default.
• W2026499711 hasConcept C178790620 @default.
• W2026499711 hasConcept C185592680 @default.
• W2026499711 hasConcept C203014093 @default.
• W2026499711 hasConcept C2778690821 @default.
• W2026499711 hasConcept C2778695967 @default.
• W2026499711 hasConcept C3020625565 @default.
• W2026499711 hasConcept C49039625 @default.
• W2026499711 hasConcept C55493867 @default.
• W2026499711 hasConcept C74172505 @default.
• W2026499711 hasConcept C86803240 @default.
• W2026499711 hasConcept C95444343 @default.
• W2026499711 hasConceptScore W2026499711C178790620 @default.
• W2026499711 hasConceptScore W2026499711C185592680 @default.
• W2026499711 hasConceptScore W2026499711C203014093 @default.
• W2026499711 hasConceptScore W2026499711C2778690821 @default.
• W2026499711 hasConceptScore W2026499711C2778695967 @default.
• W2026499711 hasConceptScore W2026499711C3020625565 @default.
• W2026499711 hasConceptScore W2026499711C49039625 @default.
• W2026499711 hasConceptScore W2026499711C55493867 @default.
• W2026499711 hasConceptScore W2026499711C74172505 @default.
• W2026499711 hasConceptScore W2026499711C86803240 @default.
• W2026499711 hasConceptScore W2026499711C95444343 @default.
• W2026499711 hasIssue "13" @default.
• W2026499711 hasLocation W20264997111 @default.
• W2026499711 hasOpenAccess W2026499711 @default.
• W2026499711 hasPrimaryLocation W20264997111 @default.
• W2026499711 hasRelatedWork W1986308161 @default.
• W2026499711 hasRelatedWork W1998701182 @default.
• W2026499711 hasRelatedWork W2024473659 @default.
• W2026499711 hasRelatedWork W2036782133 @default.
• W2026499711 hasRelatedWork W2092109545 @default.
• W2026499711 hasRelatedWork W2948395022 @default.
• W2026499711 hasRelatedWork W2952108139 @default.
• W2026499711 hasRelatedWork W2952789117 @default.
• W2026499711 hasRelatedWork W3128606776 @default.
• W2026499711 hasRelatedWork W4295681336 @default.
• W2026499711 hasVolume "271" @default.

• next